Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.
Description
At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
AarogyaAI
Country
India
Website
aarogya.ai/
Vendor Details
Company Name
Genospace
Country
United States
Website
www.genospace.com